Among GSTOs, only the GSTO2*N142D polymorphism was evaluated in subjects affected by different types of skin cancers, i.e., squamous cell carcinomas, basal cell carcinoma, malignant melanomas, and non-malignant lesions (benign). This evidence concerns the gene GSTO2 and skin neoplasm.